The Ability of Surgery in T4 Lung Cancer

The Ability of Surgery in T4 Lung Cancer

According to the staging system, T4 cases have been identified as tumors larger than 7cm or invasive tumors on tissues, suchas the diaphragm, mediastinum, heart, large vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or separatetumor nodule(s) on a different lobe on the same side. In this manuscript, the srugical treatment of T4 N0-1 lung cancer that madetracheal, carina, vertebra, thoracic inlet, vena cava superior, mediastinal structures and diyafragmatic invasion. Medical literaturein the thoracic surgery and oncology network was reviewed, and studies, cases, and meta-analysis studies that included surgicaltreatment practices in oligometastatic small cell lung cancer treatment and their results were examined. A discussion was made byalso analyzing the survival data in light of the literature studies and available guidelines. In recent years, indications of lung cancersurgery have also been expanded in parallel with the advancements in multidisciplinary surgery and in multidisciplinary oncologicaltreatment protocols, and thus surgery has become applicable for more patients. T4 N 0-1 cases are approximately 30 % of alllung cancer cases and despite 5 year survival is about 10 %, there are survival advantages in patients who have complete resection.T4 tumor surgery should be applied in experienced centers and by multidisciplinary surgery teams. Treatment decisions should beindividualized, and complete surgery should be considered for NO-1 cases whose activity rate could be high.

___

  • Turna A, Ak G, Kömürcüoğlu BE, Yurt S, Yılmaz Ü. Küçük hücreli dışı akciğer kanserinde sekizinci evreleme ve uygulamadaki etkileri. Turk J Thorac Cardiovasc Surg 2017; 25: 484-98. [CrossRef]
  • Bedirhan MA. Karina rezeksiyonları: Genel bir bakış. Aydoğmuş Ü, editör. İstanbul: Derman tıbbı yayıncılık; 2016.p.120-30.
  • Regnard JF, Perrotin C, Giovannetti R, Schussler O, Petino A, Spaggiari L, et al. Resection for tumors with carinal involvement: technical aspects, results, and prognostic factors. Ann Thorac Surg 2005; 80: 1841-6. [CrossRef]
  • Yaran P, Yazıcı Ü, Taştepe İ. Akciğer kanserinde genişletilmiş rezeksiyonlar. JCAM. 2010; 519: 32-40.
  • Dartevelle PG, Mitilian D, Fadel E. Extended surgery for T4 lung cancer: a 30 years’ experience. Gen Thorac Cardiovasc Surg 2017; 65: 321-8. [CrossRef]
  • Yamamoto K, Miyamoto Y, Ohsumi A, Imanishi N, Kojima F. Results of surgical resection for tracheobronchial cancer involving the tracheal carina. Gen Thorac Cardiovasc Surg 2007; 55: 231-9; discussion 238-9. [CrossRef]
  • Mısırlıoğlu AK, Kır A, Koşar A, Kadıoğlu SZ, Atasalihi A. Barclay tekniği ile karina rezeksiyonu. Turk J Thorac Cardiovasc Surg 2008; 16: 265-8.
  • De Meester TR, Albertucci M, Dawson PJ, Montner SM. Management of tumor adherent to the vertebral column. J Thorac Cardiovasc Surg 1989; 97: 373-8.
  • Martin LW, Walsh GL. Vertebral body resection. Thorac Surg Clin 2004; 14: 241-54. [CrossRef]
  • Koizumi K, Haraguchi S, Hirata T, Hirai K, Mikami I, Yamagishi S, et al. Surgical treatment of lung cancer with vertebral invasion. Ann Thorac Cardiovasc Surg 2004; 10: 229-34.
  • Sekine Y, Saitoh Y, Yoshino M, Koh E, Hata A, Inage T, et al. Evaluating vertebral artery dominancy before T4 lung cancer surgery requiring subclavian artery reconstruction. Surg Today 2018; 48: 158-66. [CrossRef]
  • Mitsos S, Petko M, Patrini D, Hayward M, Scarci M, Lawrence D, et al. Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy. Indian J Cancer 2017; 54: 73-81. [CrossRef]
  • Chambers A, Routledge T, Billè A, Scarci M. Best evidence topic- Thoracic oncologic. Does surgery have a role in T4N0 and T4N1 lung cancer? Interact Cardiovasc Thorac Surg 2010; 11: 473-9. [CrossRef]
  • Komaki R, Roth JA, Walsh GL, Puatnam JB, Vaporciyan A, Lee JS, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Centre. Int J Radiat Oncol Biol Phys 2000; 48: 347-54. [CrossRef]